Krka Expands Veterinary Portfolio With Launch Of Arocenia, A Maropitant Injectable
2 weeks ago 
166 views
Krka UK has announced the launch of Arocenia® 10 mg/ml injectable solution, a new addition to its expanding portfolio of generic pharmaceuticals. Containing the active ingredient maropitant, a neurokinin-1 (NK1) receptor antagonist, Arocenia® is licensed for the prevention and treatment of vomiting in dogs and cats, including perioperative use and chemotherapy-associated indications in dogs.
Unveiled at BVA Live 2025, Arocenia® provides fast, broad-spectrum anti-emetic efficacy with a 24-hour duration of action following a single daily dose. It can be administered intravenously or subcutaneously and is supplied in 20 ml multi-dose vials, allowing up to 40 punctures per vial and a 60-day open vial shelf life.
Renzo Di Florio, Krka’s Technical Veterinary Adviser, commented “Vomiting is one of the most common presenting signs in small animal practice, and maropitant is a medication you’ll find on just about every vet’s dispensary shelf. With Arocenia®, we’re adding a cost-effective formulation to the available options.”
Arocenia® supports a wide range of clinical applications, including the prevention of perioperative nausea and vomiting and improving recovery from general anaesthesia after the use of the u-receptor agonist, morphine. It also provides important antiemetic support during chemotherapy and is indicated for prevention of nausea and vomiting in cats across varied clinical contexts. Its broad indication range make it a useful option for busy small animal clinics.
Will Ridgway, Head of Animal Health at Krka UK, added “With so many pressures on practice workflow, having products that are accessible, cost-effective and reliable is essential. Arocenia® reflects that approach - and because we manage our own manufacturing in Europe, we can offer the consistency and supply reassurance that veterinary teams rely on.”
Krka continues to innovate in the animal medicine category with new generic formulations. The launch of Arocenia® further strengthens Krka’s commitment to providing practical, evidence-based solutions that support both patient outcomes and practice efficiency.
For more information visit https://www.krka.co.uk//products/our-products/animal-health/arocenia-10mgml-solution-for-injection/
More from Companion Consultancy
- VetDX launches end-to-end solution for anthelmintic resistance testing in sheep
- Krka celebrates a delectable development journey with 10 years of tasty Milprazon
- Krka UK and Tim Nuttall launch podcasts on antimicrobial stewardship in companion animal practice
- Kin Vet extends its community with Aspen Veterinary Surgery, Ewell Veterinary Centre and The Vet Whetstone
- Veterinary teams supported with new owner factsheets during peak respiratory season
2 hours ago